Tema Oncology ETF is a ETF series of Tema ETF Trust (series S000078299). Net assets $176.1M as of 2026-05-31.
Showing 15 of 57 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Revolution Medicines Inc | RVMD | $13.6M | 772.91% |
| Eli Lilly & Co | LLY | $8.5M | 482.05% |
| Roche Holding AG | RHHBY | $7.4M | 421.40% |
| Cogent Biosciences Inc | COGT | $7.2M | 409.70% |
| Novartis AG | NOVN | $7.1M | 402.94% |
| Immunome Inc | IMNM | $6.9M | 391.20% |
| Celcuity Inc | CELC | $6.3M | 357.96% |
| Merck & Co Inc | MRK | $6.3M | 357.08% |
| AstraZeneca PLC | AZN | $6.2M | 353.52% |
| Nuvalent Inc | NUVL | $5.9M | 336.94% |
| Bristol-Myers Squibb Co | BMY | $5.8M | 330.08% |
| Legend Biotech Corp | LEGN | $5.3M | 299.28% |
| AbbVie Inc | ABBV | $4.9M | 280.58% |
| Exelixis Inc | EXEL | $4.9M | 277.66% |
| Bridgebio Pharma Inc | BBIO | $4.8M | 275.33% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $176.1M |
| 2026-02-28 | $159.9M |
| 2025-11-30 | $104.8M |
| 2025-08-31 | $70.4M |
| 2025-05-31 | $66.8M |
| 2025-02-28 | $67.6M |
| 2024-11-30 | $48.9M |
| 2024-08-31 | $51.3M |